DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-02-22 07:30 |
DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal O…
|
English | 194.5 KB | ||
| 2021-02-19 07:30 |
DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Confe…
|
English | 132.4 KB | ||
| 2021-02-19 07:30 |
DBV Technologies invitée à participer à la SVB Leerink Global Partners Healthca…
|
French | 178.5 KB | ||
| 2021-02-11 22:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions…
|
French | 97.0 KB | ||
| 2021-02-11 22:30 |
Monthly information regarding the total number of voting rights and total numbe…
|
English | 160.3 KB | ||
| 2021-01-29 22:30 |
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
|
French | 189.7 KB | ||
| 2021-01-29 22:30 |
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
|
English | 191.0 KB | ||
| 2021-01-14 22:30 |
DBV Technologies annonce des avancées règlementaires sur ViaskinTM Peanut pour …
|
French | 198.3 KB | ||
| 2021-01-14 22:30 |
DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Childre…
|
English | 193.7 KB | ||
| 2021-01-07 07:30 |
DBV Technologies annonce un changement dans le statut de reporting aux États-Un…
|
French | 158.7 KB | ||
| 2021-01-07 07:30 |
DBV Technologies Announces Change in U.S. Reporting Status and Final Approval o…
|
English | 154.5 KB | ||
| 2021-01-05 22:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 97.0 KB | ||
| 2021-01-05 22:30 |
Monthly information regarding the total number of voting rights and total numbe…
|
English | 160.4 KB | ||
| 2020-12-15 22:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 96.7 KB | ||
| 2020-12-15 22:30 |
Monthly information regarding the total number of voting rights and total numbe…
|
English | 160.4 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
